Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gussek, Philipp
15  Ergebnisse:
Personensuche X
?
1

Analytical Validation of an Immunohistochemical 7-Biomarker..:

Ziemer, Mirjana ; Weidenthaler-Barth, Beate ; Gussek, Philipp...
Diagnostics.  13 (2023)  19 - p. 3096 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Pretreatment metastatic growth rate determines clinical out..:

Wagner, Nikolaus B ; Lenders, Max M ; Kühl, Kathrin...
Journal for ImmunoTherapy of Cancer.  9 (2021)  5 - p. e002350 , 2021
Link: https://doi.org/10.1136/..
 
?
3

Distinct Immune Signatures Indicative of Treatment Response..:

Reschke, Robin ; Gussek, Philipp ; Boldt, Andreas...
International Journal of Molecular Sciences.  22 (2021)  15 - p. 8017 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Identifying High-Risk Tumors within AJCC Stage IB–III Melan..:

Reschke, Robin ; Gussek, Philipp ; Ziemer, Mirjana
Cancers.  13 (2021)  12 - p. 2902 , 2021
Link: https://doi.org/10.3390/..
 
?
5

Effects of high‐dose ethanol intoxication and hangover on c..:

Wolff, Nicole ; Gussek, Philipp ; Stock, Ann‐Kathrin.
Addiction Biology.  23 (2016)  1 - p. 503-514 , 2016
Link: https://doi.org/10.1111/..
 
?
6

Pretreatment metastatic growth rate determines clinical out..:

Wagner, Nikolaus B ; Lenders, Max M ; Kühl, Kathrin...
https://mediatum.ub.tum.de/1653380.  , 2021
Link: https://mediatum.ub.tum...
 
?
7

Distinct Immune Signatures Indicative of Treatment Response..:

Reschke, Robin ; Gussek, Philipp ; Boldt, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348898/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Identifying High-Risk Tumors within AJCC Stage IB–III Melan..:

Reschke, Robin ; Gussek, Philipp ; Ziemer, Mirjana
2072-6694.  , 2021
Link: https://nbn-resolving.or..
 
?
9

Pretreatment metastatic growth rate determines clinical out..:

Wagner, Nikolaus B ; Lenders, Max M ; Kühl, Kathrin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126291/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Analytical Validation of an Immunohistochemical 7-Biomarker..:

Mirjana Ziemer ; Beate Weidenthaler-Barth ; Philipp Gussek...
https://www.mdpi.com/2075-4418/13/19/3096.  , 2023
Link: https://doi.org/10.3390/..
 
?
11

Pretreatment metastatic growth rate determines clinical out..:

Carola Berking ; Thomas K Eigentler ; Andrea Forschner...
https://jitc.bmj.com/content/9/5/e002350.full.  , 2021
Link: https://doi.org/10.1136/..
 
?
12

Distinct Immune Signatures Indicative of Treatment Response..:

Robin Reschke ; Philipp Gussek ; Andreas Boldt...
Molecular Immunology.  , 2021
Link: https://doi.org/10.3390/..
 
?
13

Identifying High-Risk Tumors within AJCC Stage IB–III Melan..:

Robin Reschke ; Philipp Gussek ; Mirjana Ziemer
https://www.mdpi.com/2072-6694/13/12/2902.  , 2021
Link: https://doi.org/10.3390/..
 
?
14

Identifying High-Risk Tumors within AJCC Stage IB–III Melan..:

Robin Reschke ; Philipp Gussek ; Mirjana Ziemer
Cancer Therapy.  , 2021
Link: https://doi.org/10.3390/..
 
?
15

Distinct Immune Signatures Indicative of Treatment Response..:

Robin Reschke ; Philipp Gussek ; Andreas Boldt...
https://www.mdpi.com/1422-0067/22/15/8017.  , 2021
Link: https://doi.org/10.3390/..
 
1-15